Barchart.com
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals Inc (ATNM)
1.9200 x 74 1.9500 x 68
Post-market by (Cboe BZX)
1.8900 +0.0200 (+1.07%) 03/27/25 [NYSE Arca]
1.9200 x 74 1.9500 x 68
Post-market 1.9497 +0.0597 (+3.16%) 18:30 ET
News & Headlines for Thu, Mar 27th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements FinancialNewsMedia - Thu Mar 27, 7:30AM CDT

EQNX::TICKER_START (NYSE:ATNM),(NYSE:BMY),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AZN) EQNX::TICKER_END

AZN : 72.84 (+0.17%)
LLY : 821.67 (-0.62%)
NVS : 111.40 (+1.14%)
ATNM : 1.8900 (+1.07%)
BMY : 58.90 (-0.52%)
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week Stocktwits - Sun Mar 23, 10:32PM CDT

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.

GCTK : 0.2323 (-4.17%)
TCBP : 0.5000 (-67.53%)
ABBV : 202.72 (+0.71%)
ATNM : 1.8900 (+1.07%)
RGC : 34.87 (-10.13%)
Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-A’s Backbone Therapy Strategy FinancialNewsMedia - Thu Mar 20, 8:31AM CDT

New York, NY – March 20, 2025 – Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced that is has...

ATNM : 1.8900 (+1.07%)
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates Zacks Investment Research - Thu Oct 31, 2024

Amarin Corporation plc AMRN reported an adjusted loss of 5 cents per share for the third quarter of 2024, which was in line with the Zacks Consensus Estimate. The company had reported breakeven earnings...

FOLD : 8.59 (+0.82%)
AMRN : 0.4673 (+1.59%)
ARDX : 5.14 (+1.98%)
ATNM : 1.8900 (+1.07%)
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View Zacks Investment Research - Thu Oct 31, 2024

Corcept Therapeutics Incorporated CORT reported third-quarter 2024 earnings of 41 cents per share, which significantly beat the Zacks Consensus Estimate of 27 cents. The company had reported earnings of...

FOLD : 8.59 (+0.82%)
CORT : 56.68 (-0.75%)
ARDX : 5.14 (+1.98%)
ATNM : 1.8900 (+1.07%)
Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions Newsfile - Tue Jun 18, 2024

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 18, 2024) - Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases the second of a...

ATNM : 1.8900 (+1.07%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase FinancialNewsMedia - Mon Jun 17, 2024

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END

ATNM : 1.8900 (+1.07%)
BPTH : 0.1700 (+6.25%)
LGVN : 1.7000 (-1.16%)
SLS : 1.1600 (-1.69%)
BMY : 58.90 (-0.52%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase GlobeNewswire - Mon Jun 17, 2024

ATNM : 1.8900 (+1.07%)
BPTH : 0.1700 (+6.25%)
LGVN : 1.7000 (-1.16%)
SLS : 1.1600 (-1.69%)
BMY : 58.90 (-0.52%)
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies FinancialNewsMedia - Mon Jun 17, 2024

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END

SNDX : 13.56 (+3.27%)
ATNM : 1.8900 (+1.07%)
KURA : 7.14 (unch)
BMEA : 2.49 (-1.19%)
JNJ : 163.13 (+0.87%)
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies GlobeNewswire - Mon Jun 17, 2024

SNDX : 13.56 (+3.27%)
ATNM : 1.8900 (+1.07%)
KURA : 7.14 (unch)
BMEA : 2.49 (-1.19%)
JNJ : 163.13 (+0.87%)

Barchart Exclusives

Should You Buy the Dip in Rigetti Computing Stock in March 2025? Barchart - Thu Mar 27, 3:37PM CDT
Rigetti Computing and other quantum computing stocks have been hit hard. So, is now the time to buy the dip? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot